Other
Neoplasm by Obsolete Classification
CI-CAN-00000033Explore in graph →
Non-malignant11 active trials5 evidence items
- NCIt
- C45230
Loading cancer entity…
Other
CI-CAN-00000033Explore in graph →
Clinical trials
51 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00012376 | Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid Cancer | completed | Phase 1 | 35 | National Cancer Institute (NCI)NIH | 1 | Jan 9, 2013 | clinicaltrials |